Pacer Advisors Inc. Has $20.64 Million Stake in USANA Health Sciences, Inc. (NYSE:USNA)

Pacer Advisors Inc. lifted its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 16.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 544,256 shares of the company’s stock after purchasing an additional 76,904 shares during the period. Pacer Advisors Inc. owned approximately 2.86% of USANA Health Sciences worth $20,638,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. Pzena Investment Management LLC lifted its position in shares of USANA Health Sciences by 7.5% during the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after purchasing an additional 72,977 shares in the last quarter. Quest Partners LLC bought a new stake in shares of USANA Health Sciences during the third quarter worth approximately $250,000. Royce & Associates LP raised its stake in shares of USANA Health Sciences by 22.2% during the third quarter. Royce & Associates LP now owns 33,143 shares of the company’s stock worth $1,257,000 after buying an additional 6,031 shares during the last quarter. KBC Group NV raised its stake in shares of USANA Health Sciences by 96.6% during the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after buying an additional 519 shares during the last quarter. Finally, Harbor Capital Advisors Inc. raised its stake in shares of USANA Health Sciences by 44.1% during the third quarter. Harbor Capital Advisors Inc. now owns 8,859 shares of the company’s stock worth $336,000 after buying an additional 2,713 shares during the last quarter. 54.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, DA Davidson dropped their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating for the company in a research note on Wednesday, October 23rd.

USANA Health Sciences Price Performance

USNA opened at $39.90 on Friday. USANA Health Sciences, Inc. has a fifty-two week low of $34.15 and a fifty-two week high of $54.81. The firm has a 50 day simple moving average of $37.80 and a 200 day simple moving average of $41.77. The company has a market cap of $760.49 million, a price-to-earnings ratio of 14.10, a price-to-earnings-growth ratio of 1.34 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $200.22 million during the quarter, compared to analysts’ expectations of $208.45 million. During the same quarter in the prior year, the company posted $0.59 earnings per share. As a group, analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Buying and Selling at USANA Health Sciences

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.33% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.